Stock Price Targets and Analyst Ratings All RatingsU.S.U.K.CanadianUpgradesDowngradesInitiationsPrice Target ChangesMore Reporting Date Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Price Target Change Action All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsBHLBBerkshire Hills Bancorp Target Raised byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$28.66+0.2%$32.00 ➝ $34.50Market Perform ➝ Market PerformBLINBridgeline Digital Reiterated byWestpark CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.25-14.4%Hold ➝ HoldBRKLBrookline Bancorp Downgraded byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. O'connellSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.96+0.1% $14.50Outperform ➝ Market PerformBRXBrixmor Property Group Target Lowered byEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingS. SakwaSubscribe to MarketBeat All Access for the recommendation accuracy rating$27.72+0.7%$32.00 ➝ $31.00In-Line ➝ In-LineBTCSBTCS Target Raised byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.86+15.8%$3.00 ➝ $5.00Buy ➝ BuyCRWDCrowdStrike Target Raised byThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$365.79+1.2%$372.00 ➝ $415.00Buy ➝ BuyWall St. Icon: “If you wait on this, it will already be too late” (Ad)If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warningDESPDespegar.com Upgraded byTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingK. KopelmanSubscribe to MarketBeat All Access for the recommendation accuracy rating$19.45-0.1%Sell ➝ HoldDXLGDestination XL Group Target Lowered byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.79+6.9%$3.50 ➝ $3.00Buy ➝ BuyEATBrinker International Upgraded byArgusSubscribe to MarketBeat All Access for the recommendation accuracy ratingW. SeleskySubscribe to MarketBeat All Access for the recommendation accuracy rating$137.19+3.1% $150.00Hold ➝ BuyENTAEnanta Pharmaceuticals Target Lowered byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$6.10-4.2%$27.00 ➝ $18.00Buy ➝ BuyFPAYFlexShopper Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.65+4.4%$2.50 ➝ $2.50Buy ➝ BuyFSSFederal Signal Reiterated byRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy rating$93.59+3.2% $110.00OutperformGANXGain Therapeutics Reiterated byRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.59+1.3%$7.00 ➝ $7.00Buy ➝ BuyGLNGGolar LNG Target Raised byStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy rating$42.80+2.3%$53.00 ➝ $55.00Buy ➝ BuyJWNNordstrom Target Lowered byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$24.21+0.2%$26.00 ➝ $24.00Market Perform ➝ Market PerformKIMKimco Realty Target Lowered byEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy rating$23.62+0.8%$24.00 ➝ $23.00In-Line ➝ In-LineMREOMereo BioPharma Group Initiated byLifesci CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$3.81+12.4% $10.00OutperformNAVINavient Target Lowered byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$13.52+2.1%$17.00 ➝ $16.00Neutral ➝ NeutralNOWServiceNow Initiated byRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy rating$1,105.56+1.6% $1,200.00OutperformOPRXOptimizeRx Target Lowered byB. RileySubscribe to MarketBeat All Access for the recommendation accuracy rating$4.94+2.3%$17.00 ➝ $13.00Buy ➝ BuyOPRXOptimizeRx Reiterated byLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.94+2.3%$11.00 ➝ $11.00Buy ➝ BuyOTEXOpen Text Target Lowered byTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$28.01+0.2%$40.00 ➝ $38.00BuyPDFSPDF Solutions Reiterated byNorthland SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$28.61+0.2%$45.00 ➝ $45.00Outperform ➝ OutperformPLYAPlaya Hotels & Resorts Reiterated byTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy rating$12.25-0.8%$13.00 ➝ $13.00Buy ➝ BuyPORPortland General Electric Target Lowered byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$43.77-1.0%$46.00 ➝ $43.00Underperform ➝ UnderperformRAREUltragenyx Pharmaceutical Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$43.75-0.3%$95.00 ➝ $95.00Buy ➝ BuyRCELAVITA Medical Initiated byD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$12.91+9.9% $25.00BuyRCELAVITA Medical Reiterated byCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy rating$12.91+9.9%$21.00 ➝ $21.00Overweight ➝ OverweightREGRegency Centers Target Lowered byEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingS. KhanalSubscribe to MarketBeat All Access for the recommendation accuracy rating$74.50+1.0%$78.00 ➝ $77.00In-Line ➝ In-LineUEUrban Edge Properties Target Lowered byEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy rating$21.59+0.5%$23.00 ➝ $22.00In-Line ➝ In-LineVRARThe Glimpse Group Reiterated byWestpark CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. RyanSubscribe to MarketBeat All Access for the recommendation accuracy rating$3.42-17.2%$4.67 ➝ $4.67Buy ➝ BuyWGOWinnebago Industries Target Lowered byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$47.89-0.2%$55.00 ➝ $54.00Neutral ➝ NeutralWULFTeraWulf Reiterated byNorthland SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$6.23+7.2%$10.00 ➝ $10.00Outperform ➝ OutperformZURAZura Bio Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. KapoorSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.32-2.5%$5.00 ➝ $5.00Neutral ➝ NeutralAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:32 AM ET. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
